Key facts
- This page summarizes Edward P. Owens's Form 4 filing for IRONWOOD PHARMACEUTICALS INC (IRWD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Jun 2021, 16:17.
Edward P. Owens - 02 Jun 2021 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)
- Reporting relationship
- Director
- Issuer ticker
- IRWD
- Reported as of
- 02 Jun 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Brian Tessler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Edward P. Owens filed Form 4 for IRONWOOD PHARMACEUTICALS INC (IRWD) on 04 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IRWD
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +22,766
- Change %
- +10%
- Price
- $0.000000
- Shares after
- 241,720
- Date
- 02 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
IRWD
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 40,000
- Date
- 02 Jun 2021
- Ownership
- The Owens Family Foundation
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
Footnote F2
The reporting person and certain members of his family are trustees of the foundation, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities.